Compared to healthy individuals, DLBCL patients, especially those at high risk, exhibited decreased counts of CD3+, CD4+, and CD8+ T cells, as well as natural killer (NK) cells [84]. This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.